Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
AssigneeSavior Lifetec Corporation
InventorsWei-Hong Tseng, Wen-Hsin Chang, Chia-Mao Chang, Chia-Wei Yeh, Yuan-Liang Kuo
Life of this patent
Estimating the term…
Abstract
The present invention relates to an efficient process of synthesizing some known Ertapenem compounds and to provide new intermediate compounds of Meropenem and Doripenem. The process and the intermediate can substantially increase the effective yield and reduce the impurity generation. The present invention further provides a novel and effective process for recovering and purifying ertapenem compounds by utilizing a low cost, materials with chemical stability as a carrier for isolating ertapenem compounds from extracts.
Claims14
A process for the preparation of a compound of formula II:
- or a pharmaceutically acceptable salt thereof, wherein R is hydrogen and M and M′ are hydrogen, sodium ion, or potassium ion comprising:
- i) providing a compound of formula I:
- ii) converting the compound of formula I into the compound of formula II, wherein Ar is 2,4-dichlorophenyl or phenyl, P is phosphorous, and P′ is selected from the group consisting of alkyl, 2,2,2,-trichloroethyl, 2-bromoethyl, benzhydryl, trityl, aryl, trimethylsilyl, triethylsilyl, 4-methoxybenzyl, t-butyl, p-nitrobenzyl and hydrogen;
- and wherein the converting comprises the step of condensing the compound of formula I with a compound of formula V:
- to form a compound of formula VI:
- wherein P″ is selected from the group consisting of alkyl, 2,2,2,-trichloroethyl, dibromoethyl, benzhydryl, trityl, aryl, trimethylsilyl, triethylsilyl, 4-methoxybenzyl, t-butyl, p-nitrobenzyl and hydrogen;
- wherein the compound of formula VI is converted into the compound of formula II by hydrogenolysis in presence of a metal catalyst, a base, water and a first organic solvent to produce a first solution of the compound of formula II, and the compound of formula II is obtained from the first solution of the compound of formula II by
- (a) adjusting a pH value to 5.0 to 5.4 of the first solution of the compound of formula II and then filtering out the metal catalyst;
- (b) separating an aqueous layer from the first solution of the compound of formula II and removing the first organic solvent from the aqueous layer by distillation or extraction;
- (c) extracting a first aqueous concentrated extract from the aqueous layer with dichloromethane under the pH value of the aqueous layer adjusted to 6.3-6.7, and then extracting a second aqueous concentrated extract with n-butanol or isoamyl alcohol (IAA);
- (d) filtering the second aqueous concentrated extract to obtain an aqueous concentrated solution and adding isopropanol (IPA) or a mixture of methanol and tetrahydrofuran in the aqueous concentrated solution then chilled to a temperature of −8˜0° C.;
- (e) adding a mixture of methanol and tetrahydrofuran or a mixture of methanol and methyl acetate in the aqueous concentrated solution and adjusting the pH value to 5.7 thereof;
- (f) adding a mixture solvent of isopropanol, methanol and tetrahydrofuran or a mixture solvent of methanol and tetrahydrofuran, or a mixture of IPA, methanol and methyl acetate in the aqueous concentrated solution and adding a seed material to the aqueous concentrated solution to age thereof;
- (g) adding a crystallization solvent into the aqueous concentrated solution to crystallization then the aqueous concentrated solution is chilled to a temperature of −5˜−15° C. and filtering to obtain a crystalline compound of formula II and residual liquid;
- and
- (h) washing the crystalline compound of formula II with a mixture of methanol and tetrahydrofuran or a mixture of 1-propanol, methanol and tetrahydrofuran, or a mixture of methanol and methyl acetate, and pressing with nitrogen to remove the crystallization solvent to yield the compound of formula II,
- the first organic solvent is selected from the group consisting of tetrahydrofuran, acetonitrile, ethylacetate, propionitrile, n-butanol, methanol, ethanol, dichloromethane, NN-dimethylformamide, N-ethylpyrrolidinone, and mixtures thereof;
- and
- the crystallization solvent is a mixture selected from the group consisting of:
- (i) IPA, methanol and tetrahydrofuran;
- (ii) methanol and tetrahydrofuran;
- (iii) IPA, methanol and methyl acetate;
- and
- (iv) 1-propanol, methanol and tetrahydrofuran.
A process for the preparation of a compound of Meropenem:
- comprising:
- i) providing a compound of formula I:
- ii) converting the compound of formula I into Meropenem, wherein Ar is 2,4-dichlorophenyl, P is phosphorous, and P′ is selected from the group consisting of alkyl, 2,2,2,-trichloroethyl, 2-bromoethyl, benzhydryl, trityl, aryl, trimethylsilyl, triethylsilyl, 4-methoxybenzyl, t-butyl, p-nitrobenzyl and hydrogen;
- and wherein the converting comprises the step of condensing the compound of formula I with a compound of formula VII:
- to form a compound of formula VIII:
- wherein P″ is selected from the group consisting of alkyl, 2,2,2,-trichloroethyl, 2-bromoethyl, benzhydryl, trityl, aryl, trimethylsilyl, triethylsilyl, 4-methoxybenzyl, t-butyl, p-nitrobenzyl and hydrogen;
- wherein the compound of formula VIII is converted into the Meropenem by hydrogenolysis in presence of a metal catalyst, a base, water and tetrahydrofuran, and then Meropenem is obtained by
- (a) filtering out the metal catalyst and washing with a mixture of tetrahydrofuran and water;
- (b) diluting the filtrate with acetone and adding a seed material to precipitate;
- and
- (c) adding the acetone and filtering to collect the crystalline Meropenem.
A process for the preparation of a compound of Doripenem:
- comprising:
- i) providing a compound of formula I:
- ii) converting the compound of formula I into Doripenem, wherein Ar is 2,4-dichlorophenyl, P is phosphorous, and P′ is selected from the group consisting of alkyl, 2,2,2,-trichloroethyl, 2-bromoethyl, benzhydryl, trityl, aryl, trimethylsilyl, triethylsilyl, 4-methoxybenzyl, t-butyl, p-nitrobenzyl and hydrogen;
- and wherein the converting comprises the step of condensing the compound of formula I with a compound of formula IX:
- to form a compound of formula X:
- wherein P″ is selected from the group consisting of alkyl, 2,2,2,-trichloroethyl, 2-bromoethyl, benzhydryl, trityl, aryl, trimethylsilyl, triethylsilyl, 4-methoxybenzyl, t-butyl, p-nitrobenzyl and hydrogen;
- wherein the compound of formula X is converted into the Doripenem by hydrogenolysis in presence of a suspension of a metal catalyst, a base, water, tetrahydrofuran and MgCl2.6H2O, and then Doripenem is obtained by
- (a) filtering out the metal catalyst from the suspension and washing with a mixture of tetrahydrofuran and water;
- (b) adding MgCl2.6H2O and tetrahydrofuran in a filtrate and forming a first aqueous layer and an organic layer of the filtrate then cooling the first aqueous layer of the filtrate to 0˜5° C.:
- (c) adding a seed material and methanol in the first aqueous layer of the filtrate to form a aqueous suspension;
- (d) adding MgCl2.6H2O to the organic layer of the filtrate to form a second aqueous layer then mixing the second aqueous layer with the aqueous suspension of step (c);
- and
- (e) adding methanol into the aqueous suspension of step (d) and filtering to collect the crystalline Doripenem.
Dependencies are inferred from the claim text.